Author Correction: Immunogenicity and efficacy of fourth BNT162b2 and mRNA1273 COVID-19 vaccine doses; three months follow-up (Nature Communications, (2022), 13, 1, (7711), 10.1038/s41467-022-35480-2)

Michal Canetti, Noam Barda, Mayan Gilboa, Victoria Indenbaum, Michal Mandelboim, Tal Gonen, Keren Asraf, Yael Weiss-Ottolenghi, Sharon Amit, Ram Doolman, Ella Mendelson, Dror Harats, Laurence S. Freedman, Yitshak Kreiss, Yaniv Lustig, Gili Regev-Yochay

Research output: Contribution to journalComment/debate

Abstract

The published version of the article contained an error in Figure 2, where the incorrect panel d had been included. This has been corrected in the HTML and PDF versions.

Original languageEnglish
Article number1593
JournalNature Communications
Volume14
Issue number1
DOIs
StatePublished - Dec 2023
Externally publishedYes

Bibliographical note

Publisher Copyright:
© 2023, The Author(s).

Fingerprint

Dive into the research topics of 'Author Correction: Immunogenicity and efficacy of fourth BNT162b2 and mRNA1273 COVID-19 vaccine doses; three months follow-up (Nature Communications, (2022), 13, 1, (7711), 10.1038/s41467-022-35480-2)'. Together they form a unique fingerprint.

Cite this